Is 5-methyltetrahydrofolate an alternative to folic acid for the prevention of neural tube defects?

Journal of Perinatal Medicine

Volumn 41, Issue 5, 2013, Pages 469-483

  Obeid, Rima ^a   Holzgreve, Wolfgang ^b   Pietrzik, Klaus ^c  

^a SAARLAND UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL BONN   (Germany)

^c UNIVERSITY OF BONN   (Germany)

Author keywords

5 MethylTHF; Neural tube defects; Pregnancy

Indexed keywords

5 METHYLTETRAHYDROFOLIC ACID; BIOLOGICAL MARKER; DIHYDROFOLIC ACID; FOLIC ACID; GLYCINE HYDROXYMETHYLTRANSFERASE; TETRAHYDROFOLIC ACID;

ARTICLE; BIOAVAILABILITY; BLOOD ANALYSIS; CONCEPTION; CYANOCOBALAMIN DEFICIENCY; DIET SUPPLEMENTATION; DIETARY INTAKE; DIETARY REFERENCE INTAKE; FIRST TRIMESTER PREGNANCY; FOLATE METABOLISM; FOLIC ACID BLOOD LEVEL; GENETIC POLYMORPHISM; HOMEOSTASIS; HUMAN; METABOLITE; NEURAL TUBE DEFECT; PREGNANCY; PRIORITY JOURNAL; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; UMBILICAL CORD BLOOD;

BIOLOGICAL MARKERS; FEMALE; FETAL BLOOD; FOLIC ACID; FOLIC ACID DEFICIENCY; HUMANS; INFANT, NEWBORN; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); NEURAL TUBE DEFECTS; NUTRITIONAL REQUIREMENTS; POLYMORPHISM, SINGLE NUCLEOTIDE; PREGNANCY; RISK FACTORS; TETRAHYDROFOLATES;

EID: 84888632736     PISSN: 03005577     EISSN: 16193997     Source Type: Journal    
DOI: 10.1515/jpm-2012-0256     Document Type: Article

References (143)

1. Anderson DD, Stover PJ. SHMT1 and SHMT2 are functionally redundant in nuclear de novo thymidylate biosynthesis. PLoS ONE 2009;4:e5839.
2. Ashfield-Watt PA, Pullin CH, Whiting JM, Clark ZE, Moat SJ, Newcombe RG, et al. Methylenetetrahydrofolate reductase 677C ? T genotype modulates homocysteine responses to a folate-rich diet or a low-dose folic acid supplement: a randomized controlled trial. Am J Clin Nutr. 2002;76:180-6.
3. Bailey SW, Ayling JE. The extremely slow and variable activity of dihydrofolate reductase in human liver and its implications for high folic acid intake. Proc Natl Acad Sci USA. 2009;106:15424-9.
4. Bailey RL, Dodd KW, Gahche JJ, Dwyer JT, McDowell MA, Yetley EA, et al. Total folate and folic acid intake from foods and dietary supplements in the USA: 2003-2006. Am J Clin Nutr. 2010;91:231-7.
5. Baker PN, Wheeler SJ, Sanders TA, Thomas JE, Hutchinson CJ, Clarke K, et al. A prospective study of micronutrient status in adolescent pregnancy. Am J Clin Nutr. 2009;89:1114-24.
6. Barbour RS, Macleod M, Mires G, Anderson AS. Uptake of folic acid supplements before and during pregnancy: focus group analysis of women's views and experiences. J Hum Nutr Diet. 2012;25:140-7.
7. Beaudin AE, Abarinov EV, Noden DM, Perry CA, Chu S, Stabler SP, et al. Shmt1 and de novo thymidylate biosynthesis underlie folate-responsive neural tube defects in mice. Am J Clin Nutr. 2011;93:789-98.
8. Beaudin AE, Perry CA, Stabler SP, Allen RH, Stover PJ. Maternal Mthfd1 disruption impairs fetal growth but does not cause neural tube defects in mice. Am J Clin Nutr. 2012;95:882-91.
9. Bentley S, Hermes A, Phillips D, Daoud YA, Hanna S. Comparative effectiveness of a prenatal medical food to prenatal vitamins on hemoglobin levels and adverse outcomes: a retrospective analysis. Clin Ther. 2011;33:204-10.
10. Bergen NE, Jaddoe VW, Timmermans S, Hofman A, Lindemans J, Russcher H, et al. Homocysteine and folate concentrations in early pregnancy and the risk of adverse pregnancy outcomes: the Generation R Study. BJOG. 2012;119:739-51.
11. Berry RJ, Li Z, Erickson JD, Li S, Moore CA, Wang H, et al. Prevention of neural-tube defects with folic acid in China. China -U.S. Collaborative Project for Neural Tube Defect Prevention. N Engl J Med. 1999;341:1485-90.
12. Berti C, Fekete K, Dullemeijer C, Trovato M, Souverein OW, Cavelaars A, et al. Folate intake and markers of folate status in women of reproductive age, pregnant and lactating women: a meta-Analysis. J Nutr Metab. 2012;2012:470656.
13. Bhandari SD, Gregory JF III. Folic acid, 5-methyl-tetrahydrofolate and 5-formyl-tetrahydrofolate exhibit equivalent intestinal absorption, metabolism and in vivo kinetics in rats. J Nutr. 1992;122:1847-54.
14. Bodnar LM, Himes KP, Venkataramanan R, Chen JY, Evans RW, Meyer JL, et al. Maternal serum folate species in early pregnancy and risk of preterm birth. Am J Clin Nutr. 2010;92:864-71.
15. Bostom AG, Shemin D, Bagley P, Massy ZA, Zanabli A, Christopher K, et al. Controlled comparison of L-5-methyltetrahydrofolate versus folic acid for the treatment of hyperhomocysteinemia in hemodialysis patients. Circulation. 2000;101:2829-32.
16. Bower C, Stanley FJ. Periconceptional vitamin supplementation and neural tube defects; evidence from a case-control study in Western Australia and a review of recent publications. J Epidemiol Community Health. 1992;46:157-61.
17. Brody LC, Conley M, Cox C, Kirke PN, McKeever MP, Mills JL, et al. A polymorphism, R653Q, in the trifunctional enzyme methylenetetrahydrofolate dehydrogenase/methenyltetrahydrofolate cyclohydrolase/formyltetrahydrofolate synthetase is a maternal genetic risk factor for neural tube defects: report of the Birth Defects Research Group. Am J Hum Genet. 2002;71:1207-15.
18. Brouwer IA, van Dusseldorp M, West CE, Meyboom S, Thomas CM, Duran M, et al. Dietary folate from vegetables and citrus fruit decreases plasma homocysteine concentrations in humans in a dietary controlled trial. J Nutr. 1999;129:1135-9.
19. Brouwer IA, Van Dusseldorp M, West CE, Steegers-Theunissen RP. Bioavailability and bioefficacy of folate and folic acid in man. Nutr Res Rev. 2001;14:267-94.
20. Brown JE, Jacobs DR Jr., Hartman TJ, Barosso GM, Stang JS, Gross MD, et al. Predictors of red cell folate level in women attempting pregnancy. J Am Med Assoc. 1997;277:548-52.
21. Caudill MA. Folate bioavailability: implications for establishing dietary recommendations and optimizing status. Am J Clin Nutr. 2010;91:1455S-60S.
22. Centers for Disease Control and Prevention. Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. MMWR Recomm Rep. 1992;41:1-7.
23. Christensen KE, Rohlicek CV, Andelfinger GU, Michaud J, Bigras JL, Richter A, et al. The MTHFD1 p.Arg653Gln variant alters enzyme function and increases risk for congenital heart defects. Hum Mutat. 2009;30:212-20.
24. Coppen A, Bailey J. Enhancement of the antidepressant action of fluoxetine by folic acid: a randomised, placebo controlled trial. J Affect Disord. 2000;60:121-30.
25. Crider KS, Zhu JH, Hao L, Yang QH, Yang TP, Gindler J, et al. MTHFR 677C-> T genotype is associated with folate and homocysteine concentrations in a large, population-based, double-blind trial of folic acid supplementation. Am J Clin Nutr. 2011;93:1365-72.
26. Cuskelly GJ, McNulty H, Scott JM. Effect of increasing dietary folate on red-cell folate: implications for prevention of neural tube defects. Lancet. 1996;347:657-9.
27. Czeizel AE. Reduction of urinary tract and cardiovascular defects by periconceptional multivitamin supplementation. Am J Med Genet. 1996;62:179-83.
28. Czeizel AE, Dudas I. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med. 1992;327:1832-5.
29. Czeizel AE, Susanszky E. Diet intake and vitamin supplement use of Hungarian women during the preconceptional period. Int J Vitam Nutr Res. 1994;64:300-5.
30. Czeizel AE, Puho EH, Langmar Z, Acs N, Banhidy F. Possible association of folic acid supplementation during pregnancy with reduction of preterm birth: a population-based study. Eur J Obstet Gynecol Reprod Biol. 2010;148:135-40.
31. Czeizel AE, Timar L, Sarkozi A. Dose-dependent effect of folic acid on the prevention of orofacial clefts. Pediatrics. 1999;104:e66.
32. Daly LE, Kirke PN, Molloy A, Weir DG, Scott JM. Folate levels and neural tube defects. Implications for prevention. J Am Med Assoc. 1995;274:1698-702.
33. Daly S, Mills JL, Molloy AM, Conley M, Lee YJ, Kirke PN, et al. Minimum effective dose of folic acid for food fortification to prevent neural-tube defects. Lancet. 1997;350:1666-9.
34. de Bree A, Verschuren WM, Blom HJ, Kromhout D. Association between B vitamin intake and plasma homocysteine concentration in the general Dutch population aged 20-65 years. Am J Clin Nutr. 2001;73:1027-33.
35. de Walle HE, de Jong-van den Berg LT. Ten years after the Dutch public health campaign on folic acid: the continuing challenge. Eur J Clin Pharmacol. 2008;64:539-43.
36. Fava M, Shelton RC, Zajecka JM. Evidence for the use of l-methylfolate combined with antidepressants in MDD. J Clin Psychiatry. 2011;72:e25.
37. Fekete K, Berti C, Trovato M, Lohner S, Dullemeijer C, Souverein OW, et al. Effect of folate intake on health outcomes in pregnancy: a systematic review and meta-Analysis on birth weight, placental weight and length of gestation. Nutr J. 2012;11:75.
38. Finglas PM, Witthoft CM, Vahteristo L, Wright AJ, Southon S, Mellon FA, et al. Use of an oral/intravenous dual-label stableisotope protocol to determine folic acid bioavailability from fortified cereal grain foods in women. J Nutr. 2002;132:936-9.
39. Fohr IP, Prinz-Langenohl R, Bronstrup A, Bohlmann AM, Nau H, Berthold HK, et al. 5,10-Methylenetetrahydrofolate reductase genotype determines the plasma homocysteine-lowering effect of supplementation with 5-methyltetrahydrofolate or folic acid in healthy young women. Am J Clin Nutr. 2002;75:275-82.
40. Fox JT, Stover PJ. Folate-mediated one-carbon metabolism. Vitam Horm. 2008;79:1-44.
41. Friel JK, Frecker M, Fraser FC. Nutritional patterns of mothers of children with neural tube defects in Newfoundland. Am J Med Genet. 1995;55:195-9.
42. Gellekink H, Blom HJ, van dL I, den HM. Molecular genetic analysis of the human dihydrofolate reductase gene: relation with plasma total homocysteine, serum and red blood cell folate levels. Eur J Hum Genet. 2007;15:103-9.
43. Gregory JF III. Case study: folate bioavailability. J Nutr. 2001;131:1376S-82S.
44. Gregory JF III, Bhandari SD, Bailey LB, Toth JP, Baumgartner TG, Cerda JJ. Relative bioavailability of deuterium-labeled monoglutamyl and hexaglutamyl folates in human subjects. Am J Clin Nutr. 1991;53:736-40.
45. Grosse SD, Collins JS. Folic acid supplementation and neural tube defect recurrence prevention. Birth Defects Res A Clin Mol Teratol. 2007;79:737-42.
46. Guinotte CL, Burns MG, Axume JA, Hata H, Urrutia TF, Alamilla A, et al. Methylenetetrahydrofolate reductase 677C-> T variant modulates folate status response to controlled folate intakes in young women. J Nutr. 2003;133:1272-80.
47. Hannon-Fletcher MP, Armstrong NC, Scott JM, Pentieva K, Bradbury I, Ward M, et al. Determining bioavailability of food folates in a controlled intervention study. Am J Clin Nutr. 2004;80:911-8.
48. Hao L, Ma J, Stampfer MJ, Ren A, Tian Y, Tang Y, et al. Geographical, seasonal and gender differences in folate status among Chinese adults. J Nutr. 2003;133:3630-5.
49. Hao L, Yang QH, Li Z, Bailey LB, Zhu JH, Hu DJ, et al. Folate status and homocysteine response to folic acid doses and withdrawal among young Chinese women in a large-scale randomized double-blind trial. Am J Clin Nutr. 2008;88: 448-57.
50. Hayes C, Werler MM, Willett WC, Mitchell AA. Case-control study of periconceptional folic acid supplementation and oral clefts. Am J Epidemiol. 1996;143:1229-34.
51. Heseker HB, Mason JB, Selhub J, Rosenberg IH, Jacques PF. Not all cases of neural-tube defect can be prevented by increasing the intake of folic acid. Br J Nutr. 2009;102:173-80.
52. Hogg BB, Tamura T, Johnston KE, Dubard MB, Goldenberg RL. Second-trimester plasma homocysteine levels and pregnancyinduced hypertension, preeclampsia, and intrauterine growth restriction. Am J Obstet Gynecol. 2000;183:805-9.
53. Holmes VA, Wallace JM, Alexander HD, Gilmore WS, Bradbury I, Ward M, et al. Homocysteine is lower in the third trimester of pregnancy in women with enhanced folate status from continued folic acid supplementation. Clin Chem. 2005;51:629-34.
54. Holzgreve W, Pietrzik K, Koletzko B, Eckmann-Scholz C. Adding folate to the contraceptive pill: a new concept for the prevention of neural tube defects. J Matern Fetal Neonatal Med. 2012;25:1529-36.
55. Houghton LA, Sherwood KL, Pawlosky R, Ito S, O'Connor DL. [6S]-5-Methyltetrahydrofolate is at least as effective as folic acid in preventing a decline in blood folate concentrations during lactation. Am J Clin Nutr. 2006;83:842-50.
56. Hung J, Yang TL, Urrutia TF, Li R, Perry CA, Hata H, et al. Additional food folate derived exclusively from natural sources improves folate status in young women with the MTHFR 677 CC or TT genotype. J Nutr Biochem. 2006;17:728-34.
57. Iniesta MD, Perez-Conesa D, Garcia-Alonso J, Ros G, Periago MJ. Folate content in tomato (Lycopersicon esculentum) influence of cultivar, ripeness, year of harvest, and pasteurization and storage temperatures. J Agric Food Chem. 2009;57:4739-45.
58. Institute of Medicine. Dietary reference intakes for thiamin, riboflavin, niacin, vitamin B6, folate, vitamin B12, pantothenic acid, biotin, and choline. Washington, DC, USA: National Academy Press; 1998:390-422.
59. Ionescu-Ittu R, Marelli AJ, Mackie AS, Pilote L. Prevalence of severe congenital heart disease after folic acid fortification of grain products: time trend analysis in Quebec, Canada. Br Med J. 2009;338:b1673.
60. Johnson CY, Little J. Folate intake, markers of folate status and oral clefts: is the evidence converging? Int J Epidemiol. 2008;37:1041-58.
61. Johnson WG, Stenroos ES, Spychala JR, Chatkupt S, Ming SX, Buyske S. New 19 bp deletion polymorphism in intron-1 of dihydrofolate reductase (DHFR): a risk factor for spina bifida acting in mothers during pregnancy? Am J Med Genet A. 2004;124A:339-45.
62. Kalmbach RD, Choumenkovitch SF, Troen AP, Jacques PF, D'Agostino R, Selhub J. A 19-base pair deletion polymorphism in dihydrofolate reductase is associated with increased unmetabolized folic acid in plasma and decreased red blood cell folate. J Nutr. 2008;138:2323-7.
63. Kamen BA, Smith AK. A review of folate receptor alpha cycling and 5-methyltetrahydrofolate accumulation with an emphasis on cell models in vitro. Adv Drug Deliv Rev. 2004;56:1085-97.
64. Kelly D, O'Dowd T, Reulbach U. Use of folic acid supplements and risk of cleft lip and palate in infants: a population-based cohort study. Br J Gen Pract. 2012;62:466-72.
65. Kelly P, McPartlin J, Goggins M, Weir DG, Scott JM. Unmetabolized folic acid in serum: acute studies in subjects consuming fortified food and supplements. Am J Clin Nutr. 1997;65:1790-5.
66. Kirke PN, Molloy AM, Daly LE, Burke H, Weir DG, Scott JM. Maternal plasma folate and vitamin B12 are independent risk factors for neural tube defects. Q J Med. 1993;86:703-8.
67. Kirsch SH, Herrmann W, Geisel J, Obeid R. Assay of whole blood (6S)-5-CH(3)-H(4) folate using ultra performance liquid chromatography tandem mass spectrometry. Anal Bioanal Chem. 2012;404:895-902.
68. Krauss-Etschmann S, Shadid R, Campoy C, Hoster E, Demmelmair H, Jimenez M, et al. Effects of fish-oil and folate supplementation of pregnant women on maternal and fetal plasma concentrations of docosahexaenoic acid and eicosapentaenoic acid: a European randomized multicenter trial. Am J Clin Nutr. 2007;85:1392-400.
69. Lamers Y, Prinz-Langenohl R, Bramswig S, Pietrzik K. Red blood cell folate concentrations increase more after supplementation with [6S]-5-methyltetrahydrofolate than with folic acid in women of childbearing age. Am J Clin Nutr. 2006;84:156-61.
70. Lamers Y, Prinz-Langenohl R, Moser R, Pietrzik K. Supplementation with [6S]-5-methyltetrahydrofolate or folic acid equally reduces plasma total homocysteine concentrations in healthy women. Am J Clin Nutr. 2004;79:473-8.
71. Laurence KM, James N, Miller M, Campbell H. Increased risk of recurrence of pregnancies complicated by fetal neural tube defects in mothers receiving poor diets, and possible benefit of dietary counselling. Br Med J. 1980;281:1592-4.
72. Lewis SJ, Araya R, Leary S, Smith GD, Ness A. Folic acid supplementation during pregnancy may protect against depression 21 months after pregnancy, an effect modified by MTHFR C677T genotype. Eur J Clin Nutr. 2012;66:97-103.
73. Lowering blood homocysteine with folic acid based supplements: meta-Analysis of randomised trials. Homocysteine Lowering Trialists' Collaboration. Br Med J. 1998;316:894-8.
74. Magdelijns FJ, Mommers M, Penders J, Smits L, Thijs C. Folic acid use in pregnancy and the development of atopy, asthma, and lung function in childhood. Pediatrics. 2011;128:e135-44.
75. Martinussen MP, Risnes KR, Jacobsen GW, Bracken MB. Folic acid supplementation in early pregnancy and asthma in children aged 6 years. Am J Obstet Gynecol. 2012;206:72e1-7.
76. McKillop DJ, McNulty H, Scott JM, McPartlin JM, Strain JJ, Bradbury I, et al. The rate of intestinal absorption of natural food folates is not related to the extent of folate conjugation. Am J Clin Nutr. 2006;84:167-73.
77. Metz J, Zalusky R, Herbert V. Folic acid binding by serum and milk. Am J Clin Nutr. 1968;21:289-97.
78. Molloy AM, Daly S, Mills JL, Kirke PN, Whitehead AS, Ramsbottom D, et al. Thermolabile variant of 5,10-methylenetetrahydrofolate reductase associated with low red-cell folates: implications for folate intake recommendations. Lancet. 1997;349:1591-3.
79. Moore LL, Bradlee ML, Singer MR, Rothman KJ, Milunsky A. Folate intake and the risk of neural tube defects: an estimation of dose-response. Epidemiology. 2003;14:200-5.
80. MRC Vitamin Study Research Group. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet. 1991;338:131-7.
81. Nelen WL, Blom HJ, Steegers EA, den Heijer M, Thomas CM, Eskes TK. Homocysteine and folate levels as risk factors for recurrent early pregnancy loss. Obstet Gynecol. 2000;95:519-24.
82. Obeid R, Kasoha M, Kirsch SH, Munz W, Herrmann W. Concentrations of unmetabolized folic acid and primary folate forms in pregnant women at delivery and in umbilical cord blood. Am J Clin Nutr. 2010;92:1416-22.
83. Obeid R, Kirsch SH, Kasoha M, Eckert R, Herrmann W. Concentrations of unmetabolized folic acid and primary folate forms in plasma after folic acid treatment in older adults. Metabolism. 2011;60:673-8.
84. Obeid R, Munz W, Jager M, Schmidt W, Herrmann W. Biochemical indexes of the B vitamins in cord serum are predicted by maternal B vitamin status. Am J Clin Nutr. 2005;82:133-9.
85. Ohrvik VE, Witthoft CM. Human folate bioavailability. Nutrients. 2011;3:475-90.
86. O'Keefe CA, Bailey LB, Thomas EA, Hofler SA, Davis BA, Cerda JJ, et al. Controlled dietary folate affects folate status in nonpregnant women. J Nutr. 1995;125:2717-25.
87. Osterhues A, Holzgreve W, Michels KB. Shall we put the world on folate? Lancet. 2009;374:959-61.
88. Papadopoulou E, Stratakis N, Roumeliotaki T, Sarri K, Merlo DF, Kogevinas M, et al. The effect of high doses of folic acid and iron supplementation in early-to-mid pregnancy on prematurity and fetal growth retardation: the mother-child cohort study in Crete, Greece (Rhea study). Eur J Nutr. 2013;52:327-36.
89. Parle-McDermott A, Kirke PN, Mills JL, Molloy AM, Cox C, O'Leary VB, et al. Confirmation of the R653Q polymorphism of the trifunctional C1-synthase enzyme as a maternal risk for neural tube defects in the Irish population. Eur J Hum Genet. 2006;14:768-72.
90. Parle-McDermott A, Pangilinan F, Mills JL, Kirke PN, Gibney ER, Troendle J, et al. The 19-bp deletion polymorphism in intron-1 of dihydrofolate reductase (DHFR) may decrease rather than increase risk for spina bifida in the Irish population. Am J Med Genet A. 2007;143A:1174-80.
91. Pfeiffer CM, Caudill SP, Gunter EW, Osterloh J, Sampson EJ. Biochemical indicators of B vitamin status in the US population after folic acid fortification: results from the National Health and Nutrition Examination Survey 1999-2000. Am J Clin Nutr. 2005;82:442-50.
92. Pietrzik K, Lamers Y, Bramswig S, Prinz-Langenohl R. Calculation of red blood cell folate steady state conditions and elimination kinetics after daily supplementation with various folate forms and doses in women of childbearing age. Am J Clin Nutr. 2007;86:1414-9.
93. Qiu A, Jansen M, Sakaris A, Min SH, Chattopadhyay S, Tsai E, et al. Identification of an intestinal folate transporter and the molecular basis for hereditary folate malabsorption. Cell. 2006;127:917-28.
94. Quinlivan EP, Gregory JF III. Effect of food fortification on folic acid intake in the United States. Am J Clin Nutr. 2003;77:221-5.
95. Ramakrishnan U, Grant F, Goldenberg T, Zongrone A, Martorell R. Effect of women's nutrition before and during early pregnancy on maternal and infant outcomes: a systematic review. Paediatr Perinat Epidemiol. 2012;26:285-301.
96. Renwick JH. Spina bifida, anencephaly, and potato blight. Lancet. 1972;2:967-8.
97. Riddell LJ, Chisholm A, Williams S, Mann JI. Dietary strategies for lowering homocysteine concentrations. Am J Clin Nutr. 2000;71:1448-54.
98. Rydlewicz A, Simpson JA, Taylor RJ, Bond CM, Golden MH. The effect of folic acid supplementation on plasma homocysteine in an elderly population. QJM. 2002;95:27-35.
99. Said HM, Chatterjee N, Haq RU, Subramanian VS, Ortiz A, Matherly LH, et al. Adaptive regulation of intestinal folate uptake: effect of dietary folate deficiency. Am J Physiol Cell Physiol. 2000;279:C1889-95.
100. Sanderson P, McNulty H, Mastroiacovo P, McDowell IF, Melse-Boonstra A, Finglas PM, et al. Folate bioavailability: UK Food Standards Agency workshop report. Br J Nutr. 2003;90:473-9.
101. Sauberlich HE, Kretsch MJ, Skala JH, Johnson HL, Taylor PC. Folate requirement and metabolism in nonpregnant women. Am J Clin Nutr. 1987;46:1016-28.
102. Shaw GM, Carmichael SL, Nelson V, Selvin S, Schaffer DM. Occurrence of low birthweight and preterm delivery among California infants before and after compulsory food fortification with folic acid. Public Health Rep. 2004;119:170-3.
103. Shaw GM, Schaffer D, Velie EM, Morland K, Harris JA. Periconceptional vitamin use, dietary folate, and the occurrence of neural tube defects. Epidemiology. 1995;6:219-26.
104. Shelnutt KP, Kauwell GP, Chapman CM, Gregory JF III, Maneval DR, Browdy AA, et al. Folate status response to controlled folate intake is affected by the methylenetetrahydrofolate reductase 677C-> T polymorphism in young women. J Nutr. 2003;133:4107-11.
105. Silaste ML, Rantala M, Sampi M, Alfthan G, Aro A, Kesaniemi YA. Polymorphisms of key enzymes in homocysteine metabolism affect diet responsiveness of plasma homocysteine in healthy women. J Nutr. 2001;131:2643-7.
106. Smithells RW, Sheppard S, Schorah CJ. Vitamin deficiencies and neural tube defects. Arch Dis Child. 1976;51:944-50.
107. Solis C, Veenema K, Ivanov AA, Tran S, Li R, Wang W, et al. Folate intake at RDA levels is inadequate for Mexican American men with the methylenetetrahydrofolate reductase 677TT genotype. J Nutr. 2008;138:67-72.
108. Spiegelstein O, Mitchell LE, Merriweather MY, Wicker NJ, Zhang Q, Lammer EJ, et al. Embryonic development of folate binding protein-1 (Folbp1) knockout mice: effects of the chemical form, dose, and timing of maternal folate supplementation. Dev Dyn. 2004;231:221-31.
109. Stanislawska-Sachadyn A, Brown KS, Mitchell LE, Woodside JV, Young IS, Scott JM, et al. An insertion/deletion polymorphism of the dihydrofolate reductase (DHFR) gene is associated with serum and red blood cell folate concentrations in women. Hum Genet. 2008;123:289-95.
110. Storozhenko S, De B V, Volckaert M, Navarrete O, Blancquaert D, Zhang GF, et al. Folate fortification of rice by metabolic engineering. Nat Biotechnol. 2007;25:1277-9.
111. Suitor CW, Bailey LB. Dietary folate equivalents: interpretation and application. J Am Diet Assoc. 2000;100:88-94.
112. Sweeney MR, McPartlin J, Weir DG, Daly S, Pentieva K, Daly L, et al. Evidence of unmetabolised folic acid in cord blood of newborn and serum of 4-day-old infants. Br J Nutr. 2005;94:727-30.
113. Sweeney MR, Staines A, Daly L, Traynor A, Daly S, Bailey SW, et al. Persistent circulating unmetabolised folic acid in a setting of liberal voluntary folic acid fortification. Implications for further mandatory fortification? BMC Public Health. 2009;9:295.
114. Tighe P, Ward M, McNulty H, Finnegan O, Dunne A, Strain J, et al. A dose-finding trial of the effect of long-term folic acid intervention: implications for food fortification policy. Am J Clin Nutr. 2011;93:11-8.
115. Timmermans S, Jaddoe VW, Hofman A, Steegers-Theunissen RP, Steegers EA. Periconception folic acid supplementation, fetal growth and the risks of low birth weight and preterm birth: the Generation R Study. Br J Nutr. 2009;1-9.
116. Tolarova M. Periconceptional supplementation with vitamins and folic acid to prevent recurrence of cleft lip. Lancet. 1982;2:217.
117. Troen AM, Mitchell B, Sorensen B, Wener MH, Johnston A, Wood B, et al. Unmetabolized folic acid in plasma is associated with reduced natural killer cell cytotoxicity among postmenopausal women. J Nutr. 2006;136:189-94.
118. Tucker KL, Mahnken B, Wilson PW, Jacques P, Selhub J. Folic acid fortification of the food supply. Potential benefits and risks for the elderly population. J Am Med Assoc. 1996;276:1879-85.
119. van Beynum I, Kapusta L, Bakker MK, den Heijer M, Blom HJ, de Walle HE. Protective effect of periconceptional folic acid supplements on the risk of congenital heart defects: a registry-based case-control study in the northern Netherlands. Eur Heart J. 2010;31:464-71.
120. van der Linden IJ, Nguyen U, Heil SG, Franke B, Vloet S, Gellekink H, et al. Variation and expression of dihydrofolate reductase (DHFR) in relation to spina bifida. Mol Genet Metab. 2007;91:98-103.
121. Van Der Put NM, Eskes TK, Blom HJ. Is the common 677C-> T mutation in the methylenetetrahydrofolate reductase gene a risk factor for neural tube defects? A meta-Analysis. QJM. 1997;90:111-5.
122. Van Der Put NM, Steegers-Theunissen RP, Frosst P, Trijbels FJ, Eskes TK, van den Heuvel LP, et al. Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida. Lancet. 1995;346:1070-1.
123. van Oort FV, Melse-Boonstra A, Brouwer IA, Clarke R, West CE, Katan MB, et al. Folic acid and reduction of plasma homocysteine concentrations in older adults: a dose-response study. Am J Clin Nutr. 2003;77:1318-23.
124. Venn BJ, Green TJ, Moser R, Mann JI. Comparison of the effect of low-dose supplementation with L-5-methyltetrahydrofolate or folic acid on plasma homocysteine: a randomized placebocontrolled study. Am J Clin Nutr. 2003;77:658-62.
125. Venn BJ, Green TJ, Moser R, McKenzie JE, Skeaff CM, Mann J. Increases in blood folate indices are similar in women of childbearing age supplemented with [6S]-5-methyltetrahydrofolate and folic acid. J Nutr. 2002;132:3353-5.
126. Verhoef P. New insights on the lowest dose for mandatory folic acid fortification? Am J Clin Nutr. 2011;93:1-2.
127. Wald NJ, Law MR, Morris JK, Wald DS. Quantifying the effect of folic acid. Lancet. 2001;358:2069-73.
128. Watanabe H, Ishida S, Konno Y, Matsumoto M, Nomachi S, Masaki K, et al. Impact of dietary folate intake on depressive symptoms in young women of reproductive age. J Midwifery Womens Health. 2012;57:43-8.
129. Wei MM, Bailey LB, Toth JP, Gregory JF III. Bioavailability for humans of deuterium-labeled monoglutamyl and polyglutamyl folates is affected by selected foods. J Nutr. 1996;126:3100-8.
130. Wen SW, Chen XK, Rodger M, White RR, Yang Q, Smith GN, et al. Folic acid supplementation in early second trimester and the risk of preeclampsia. Am J Obstet Gynecol. 2008;198:45-7.
131. Werler MM, Shapiro S, Mitchell AA. Periconceptional folic acid exposure and risk of occurrent neural tube defects. J Am Med Assoc. 1993;269:1257-61.
132. Whitrow MJ, Moore VM, Rumbold AR, Davies MJ. Effect of supplemental folic acid in pregnancy on childhood asthma: a prospective birth cohort study. Am J Epidemiol. 2009;170:1486-93.
133. Winkels RM, Brouwer IA, Siebelink E, Katan MB, Verhoef P. Bioavailability of food folates is 80% of that of folic acid. Am J Clin Nutr. 2007;85:465-73.
134. Winkels RM, Brouwer IA, Verhoef P, van Oort FV, Durga J, Katan MB. Gender and body size affect the response of erythrocyte folate to folic acid treatment. J Nutr. 2008;138:1456-61.
135. Wright AJ, King MJ, Wolfe CA, Powers HJ, Finglas PM. Comparison of (6S)-5-methyltetrahydrofolic acid v. folic acid as the reference folate in longer-term human dietary intervention studies assessing the relative bioavailability of natural food folates: comparative changes in folate status following a 16-week placebo-controlled study in healthy adults. Br J Nutr. 2010;103:724-9.
136. Yamada K, Chen Z, Rozen R, Matthews RG. Effects of common polymorphisms on the properties of recombinant human methylenetetrahydrofolate reductase. Proc Natl Acad Sci USA 2001;98:14853-8.
137. Yang TL, Hung J, Caudill MA, Urrutia TF, Alamilla A, Perry CA, et al. A long-term controlled folate feeding study in young women supports the validity of the 1.7 multiplier in the dietary folate equivalency equation. J Nutr. 2005;135:1139-45.
138. Yetley EA, Pfeiffer CM, Phinney KW, Fazili Z, Lacher DA, Bailey RL, et al. Biomarkers of folate status in NHANES: a roundtable summary. Am J Clin Nutr. 2011;94:303S-12S.
139. Young PJ, Nicolas G, Freisling H, Biessy C, Scalbert A, Romieu I, et al. Comparison of standardised dietary folate intake across ten countries participating in the European Prospective Investigation into Cancer and Nutrition. Br J Nutr. 2011;1-18.
140. Zhang D, Ochi N, Takigawa N, Tanimoto Y, Chen Y, Ichihara E, et al. Establishment of pemetrexed-resistant non-small cell lung cancer cell lines. Cancer Lett. 2011;309: 228-35.
141. Zhao R, Matherly LH, Goldman ID. Membrane transporters and folate homeostasis: intestinal absorption and transport into systemic compartments and tissues. Expert Rev Mol Med. 2009;11:e4.
142. Zhao W, Mosley BS, Cleves MA, Melnyk S, James SJ, Hobbs CA. Neural tube defects and maternal biomarkers of folate, homocysteine, and glutathione metabolism. Birth Defects Res A Clin Mol Teratol. 2006;76:230-6.
143. Zhu L, Ling H. National neural tube defects prevention program in China. Food Nutr Bull. 2008;29:S196-204.